Published in Mediators Inflamm on August 10, 2016
Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene (1999) 13.46
An endothelial receptor for oxidized low-density lipoprotein. Nature (1997) 3.76
Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation (1999) 2.38
Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta (1992) 2.15
Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation (1989) 2.07
Functional and pathological roles of the 12- and 15-lipoxygenases. Prog Lipid Res (2010) 1.72
Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation (1999) 1.62
Lipid inflammatory mediators in diabetic vascular disease. Arterioscler Thromb Vasc Biol (2004) 1.61
Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler Thromb Vasc Biol (1999) 1.39
Inhibition of monocyte chemotactic protein-1 synthesis by statins. Lab Invest (2000) 1.38
Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel. Arterioscler Thromb Vasc Biol (2003) 1.35
The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids (2007) 1.35
Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis (1999) 1.34
Lipoxygenase genes and their targeted disruption. Prostaglandins Other Lipid Mediat (2002) 1.25
Oxidants and antioxidants in atherogenesis. An appraisal. J Lipid Res (1999) 1.14
Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun (1998) 1.13
Rat carotid artery balloon injury model. Methods Mol Med (2007) 1.11
Oxidized low-density lipoprotein. Methods Mol Biol (2010) 1.10
Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther (2002) 1.10
Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering. Antioxid Redox Signal (2014) 1.08
Mammalian lipoxygenases and their biological relevance. Biochim Biophys Acta (2014) 1.04
Statin treatment and 3' polyadenylation of eNOS mRNA. Arterioscler Thromb Vasc Biol (2007) 0.97
Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage. Malar J (2011) 0.96
Signaling mechanisms of nuclear factor-kappab-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2001) 0.94
A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action. Atherosclerosis (2001) 0.94
Simvastatin reduces NF-kappaB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet. Cardiovasc Res (2003) 0.92
Expression and regulation of 12/15-lipoxygenases in human primary macrophages. Atherosclerosis (2012) 0.91
Lipoxygenase metabolites induced expression of adhesion molecules and transendothelial migration of monocyte-like HL-60 cells is linked to protein kinase C activation. J Cell Physiol (1996) 0.90
Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development. PLoS One (2013) 0.88
Inhibition of intrinsic interferon-gamma function prevents neointima formation after balloon injury. Hypertension (2007) 0.86
Effects of salsalate therapy on recovery from vascular injury in female Zucker fatty rats. Diabetes (2010) 0.86
Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation. Vasc Health Risk Manag (2011) 0.83
Combinatorial interference of toll-like receptor 2 and 4 synergistically stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice. J Cell Mol Med (2011) 0.82
In vivo adenoviral gene transfer of TIMP-1 after vascular injury reduces neointimal formation. Ann N Y Acad Sci (1999) 0.82
OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators. Free Radic Biol Med (2014) 0.81
The biphasic effects of oxidized-low density lipoprotein on the vasculogenic function of endothelial progenitor cells. PLoS One (2015) 0.80
T-box20 suppresses oxidized low-density lipoprotein-induced human vascular endothelial cell injury by upregulation of PPAR-γ. Cell Physiol Biochem (2013) 0.79